For a patient facing a cancer diagnosis, the search for hope often leads far beyond the sterile walls of an oncology clinic. In the vacuum created by grueling treatment schedules and the terrifying uncertainty of a prognosis, the promise of a “miracle cure” can be an irresistible lifeline. However, a new study suggests that this desperation is being actively leveraged by celebrity influencers, leading thousands of patients to seek dangerous, unproven treatments.
According to a study published in JAMA Network Open, prescriptions for ivermectin and benzimidazole—antiparasitic drugs with no proven efficacy against malignancy—surged among U.S. Cancer patients following a high-profile podcast appearance by actor Mel Gibson. The research highlights a troubling trend: the potency of celebrity endorsement can override clinical evidence, potentially driving patients to delay or abandon life-saving conventional care in favor of anecdotal claims.
The spike in prescriptions followed a January 2025 episode of Joe Rogan’s popular podcast, in which Gibson claimed that a combination of these two antiparasitics had cured cancer in several of his friends. The episode, which garnered 60 million views within its first month, acted as a catalyst for a measurable shift in prescribing behavior across the United States.
As a physician, I have seen how the “information age” has evolved into the “misinformation age,” where a viral clip can carry more weight than a peer-reviewed trial. When a trusted or admired figure presents a medical anecdote as a breakthrough, it doesn’t just provide hope—it creates a demand that puts immense pressure on the patient-provider relationship.
The Data: A Surge in Unproven Prescriptions
The scale of the study was massive, analyzing electronic medical records from over 68 million patients across 67 different health systems in the U.S. Researchers tracked the prescribing rates of ivermectin and benzimidazole to determine if there was a correlation between the celebrity endorsement and clinical practice.
The results show a stark increase in the use of these drugs. Between January 1 and July 31, 2025, overall prescriptions for these medications doubled compared to the same period in 2024. However, the increase was significantly more pronounced among those already fighting cancer, where prescribing rates jumped 2.5 times.
| Patient Group | Prescription Increase (Jan-July 2024 vs. 2025) |
|---|---|
| General Patient Population | 2.0x (Doubled) |
| Cancer Patients | 2.5x |
The study also identified specific demographic patterns in who was most likely to receive these prescriptions. The data indicates that White patients, men and individuals living in the Southern United States were the most likely to be prescribed the ivermectin-benzimidazole combination, suggesting that the influence of the podcast reached specific cultural and geographic pockets more effectively than others.
The Science: Why ‘Cell Success’ Isn’t a Human Cure
To understand why these drugs are being discussed, one must look at the gap between laboratory research and clinical application. Some cell and animal studies have indicated that antiparasitics can produce anti-cancer activity in a petri dish or in rodents. In the world of medical research, this is a common starting point, but This proves a far cry from a cure.
Dr. Skyler B. Johnson of the University of Utah Huntsman Cancer Institute, who was not involved in the study, explains the danger of translating these findings directly to humans. According to Dr. Johnson, the dosage required to achieve any meaningful anti-cancer effect in a human would typically be considered toxic. In other words, the amount of drug needed to kill the cancer would likely kill the patient first.
Beyond direct toxicity, there is the critical issue of drug-drug interactions. Many cancer patients are on complex regimens of chemotherapy, targeted therapies, and supportive medications. Ivermectin can interfere with how the liver processes other drugs, potentially rendering chemotherapy less effective or increasing the risk of severe side effects. When a patient introduces an unproven antiparasitic into this volatile chemical mix, they are essentially conducting an uncontrolled experiment on their own body.
The ‘Influencer Effect’ and Systemic Failure
The surge in prescriptions is not merely a failure of individual judgment, but a symptom of a fractured healthcare system. Matthew Facciani, PhD, a social scientist at the Yale School of Public Health, notes that real grievances—such as the exorbitant cost of pharmaceuticals, insurance barriers, and the feeling of being “just a number” in a large hospital system—make patients vulnerable to exploitation.
When a celebrity offers a simple, accessible alternative to a complex and expensive medical system, it feels like a liberation. This “influencer effect” creates a difficult dynamic in the exam room. Michelle Rockwell, PhD, RD, a health services researcher at Virginia Tech and lead author of the study, points out that clinicians often find themselves in the impossible position of denying a medication that a patient is “passionately” convinced will help them.
This is not the first time celebrity influence has shifted public health trajectories, though the results vary wildly. Rockwell cites the “Couric Effect” from 2000, when journalist Katie Couric’s televised colonoscopy led to a 20% increase in colorectal cancer screenings. The difference, of course, is that Couric promoted a validated, life-saving screening tool, whereas the current trend promotes an unproven and potentially hazardous drug.
The Path Forward: Meeting Patients in Digital Spaces
One of the most concerning aspects of the study is the unknown variable: how many patients took these drugs instead of conventional treatment? While the study tracked prescriptions, it could not determine if patients used ivermectin as a supplement or as a replacement for chemotherapy and radiation. The latter scenario represents a public health crisis.
Facciani argues that the traditional clinical encounter—the 15-to-20-minute appointment with a doctor—is “too late and too brief” to combat the influence of a multi-hour podcast viewed by millions. He suggests that public health officials must move beyond the clinic and establish a stronger presence in the digital spaces where patients are already searching for answers.
The demographic data from the JAMA Network Open study provides a “map” for where these interventions are most needed. By identifying the populations most susceptible to this specific type of misinformation, health organizations can deploy targeted, evidence-based messaging to counter the narrative of the “secret cure.”
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Public health officials and medical boards are expected to monitor prescription data through the end of the year to determine if the spike in antiparasitic use persists or declines as more clinical warnings are issued. Further analysis of the JAMA Network Open data may be released to specifically examine the impact on patient survival rates among those who opted for unproven treatments.
Do you believe celebrity voices have too much influence over medical decisions? Share your thoughts in the comments or share this article to help spread evidence-based health information.
